» Articles » PMID: 12967799

Long-term Follow-up of Primary Glaucoma Surgery with Ahmed Glaucoma Valve Implant Versus Trabeculectomy

Overview
Journal Am J Ophthalmol
Specialty Ophthalmology
Date 2003 Sep 12
PMID 12967799
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To compare the long-term results of trabeculectomy and Ahmed glaucoma valve implant in the initial surgical management of primary open- and closed-angle glaucoma.

Design: Randomized controlled clinical trial.

Methods: One eye each of consecutive patients with primary glaucoma and without prior intraocular surgery was randomized to receive either trabeculectomy or the Ahmed implant. Large university-affiliated eye hospital in Columbo, Sri Lanka.

Results: Of 123 patients, 64 were randomized to trabeculectomy and 59 to the Ahmed implant. With a mean follow-up of 31 months, the trabeculectomy group had statistically lower intraocular pressures (IOP) during the first postoperative year. After the first year, the IOPs were comparable. No statistically significant differences between groups were noted for postoperative visual acuity, visual field, anterior chamber depth, and short-term or long-term complications. Adjunctive medication requirement was comparable for both groups. The cumulative probabilities of success (IOP <21 mm Hg and at least 15% reduction in IOP from preoperative levels) at the final follow-up period (months, 41-52) were 68.1% for trabeculectomy and 69.8% for Ahmed implant (P =.86).

Conclusions: Lower IOPs were noted for the trabeculectomy group during the first year. With longer follow-up, the IOPs and the cumulative probabilities of success were comparable between the two groups.

Citing Articles

The Road Less Traveled: Ciliary Sulcus Implantation of the Preserflo MicroShunt.

Meisel M, Berkowitz E, Schwalb A, Tiosano B Case Rep Ophthalmol. 2025; 16(1):68-73.

PMID: 39981530 PMC: 11842094. DOI: 10.1159/000543219.


Ahmed Glaucoma Valve Implantation in Jordan: Indications and Complications.

Alqudah A, Obaidi A, Al Zoubi M, Aleshawi A Clin Ophthalmol. 2024; 18:3581-3590.

PMID: 39649982 PMC: 11625418. DOI: 10.2147/OPTH.S496586.


36-Month Outcomes of Ahmed ClearPath Glaucoma Drainage Device in Severe Primary Open Angle Glaucoma.

Boopathiraj N, Wagner I, Lentz P, Checo L, Dorairaj E, Ahuja A Clin Ophthalmol. 2024; 18:1735-1742.

PMID: 38912315 PMC: 11193400. DOI: 10.2147/OPTH.S467894.


Short- to intermediate-term surgical outcome of Keiki Mehta valve implantation in refractory glaucoma.

Mitra A, Bhadra T Indian J Ophthalmol. 2023; 72(3):370-373.

PMID: 38099583 PMC: 11001242. DOI: 10.4103/IJO.IJO_688_23.


Glaucoma Drainage Device Implantation, Outcomes, and Complications.

Oatts J, Han Y Int Ophthalmol Clin. 2023; 63(4):93-101.

PMID: 37755445 PMC: 10807850. DOI: 10.1097/IIO.0000000000000499.